We are a seeded startup aiming at developing a safer and more efficient therapy for cancer using already approved treatments embeded in a de-novo polymer. The final product consists of a hydrophobic polymer with chemotherapy drug mixed in. The polymer is composed of clinically approved building blocks as well as the chemotherapeutic agent. The product will be injected to the tumor site, where it will release the drug slowly with minimal leakage to the blood stream and maxial effect on the tumor.